Stemson Therapeutics

Recent Finacing

Series A

Recent Raise

$15M

Stemson Therapeutics develops an iPSC-based cell engineering platform that differentiates iPSCs into dermal papilla cells and combines engineered cells, biomaterials, and robotic delivery to generate hair follicles.

Founded 2018

California, United States

1-10

Private

stemsontx.com

Highlights

Focus Areas

Biotechnology

Therapeutics

Recent Investors

Financials

$22.5M

Total Raised

2

Funding rounds

5

Investors

Team

Upgrade to view the team

See the team members at Stemson Therapeutics.